Protalix BioTherapeutics
PLX
#8896
Rank
HK$1.10 B
Marketcap
HK$13.76
Share price
1.14%
Change (1 day)
-0.49%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): HK$0.16

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is HK$0.16. In 2024 the company made an earnings per share (EPS) of HK$0.31 a decrease over its 2023 EPS that were of HK$0.93.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$0.16-50%
2024HK$0.31-66.67%
2023HK$0.93-138.71%
2022-HK$2.41-50%
2021-HK$4.82181.82%
2020-HK$1.71-82.11%
2019-HK$9.56-31.67%
2018-HK$13.99-72.31%
2017-HK$50.52124.14%
2016-HK$22.54-147.54%
2015HK$47.41-290.63%
2014-HK$24.876.67%
2013-HK$23.32130.77%
2012-HK$10.10-69.77%
2011-HK$33.4219.44%
2010-HK$27.98-12.2%
2009-HK$31.8636.67%
2008-HK$23.32-37.5%
2007-HK$37.3150%
2006-HK$24.873.23%
2005-HK$24.09138.46%
2004-HK$10.10-74%
2003-HK$38.86-0%
2002-HK$38.86-50%
2001-HK$77.72233.33%
2000-HK$23.32-84.21%
1999-HK$147.67-24%
1998-HK$194.30-600%
1997HK$38.86-16.67%
1996HK$46.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-HK$0.85-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$33.50 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.37 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.90 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel